Evan C. Lam
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
- Modeling and Simulation top 1%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 17
- Viral gastroenteritis research and epidemiology 5
- COVID-19 Clinical Research Studies 3
- Co-authors
- Alejandro B. Balazs (22 shared papers)Wilfredo F. García-Beltrán (9 shared papers)A. John Iafrate (7 shared papers)Aaron G. Schmidt (11 shared papers)Blake M. Hauser (11 shared papers)Jared Feldman (11 shared papers)Adam D. Nitido (6 shared papers)Kerri St. Denis (14 shared papers)
- Journals
- Cell (4 papers)Clinical Infectious Diseases (2 papers)Science Translational Medicine (2 papers)Nature Communications (2 papers)Radiotherapy and Oncology (1 paper)
- Partner nations
- United StatesSouth AfricaUnited Kingdom
In The Last Decade
Evan C. Lam
21 papers receiving 2.3k citations
Evan C. Lam's Hit Papers
Peers
Comparison fields: 5 of 98
- Infectious Diseases 2.1k
- Modeling and Simulation 219
- Health 235
- Animal Science and Zoology 277
- Immunology 351
Countries citing papers authored by Evan C. Lam
This map shows the geographic impact of Evan C. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan C. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan C. Lam more than expected).
Fields of papers citing papers by Evan C. Lam
This network shows the impact of papers produced by Evan C. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan C. Lam. The network helps show where Evan C. Lam may publish in the future.
Co-authors
The 25 scholars most cited alongside Evan C. Lam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity Hit paper breakdown → | 2021 | 849 |
| 2 | mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant Hit paper breakdown → | 2022 | 651 |
| 3 | 2020 | 407 | |
| 4 | T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals Hit paper breakdown → | 2022 | 157 |
| 5 | 2021 | 56 | |
| 6 | 2024 | 40 | |
| 7 | 2022 | 31 | |
| 8 | 2020 | 31 | |
| 9 | 2021 | 28 | |
| 10 | 2021 | 23 | |
| 11 | 2022 | 22 | |
| 12 | 2022 | 15 | |
| 13 | 2021 | 14 | |
| 14 | 2021 | 13 | |
| 15 | 2020 | 12 | |
| 16 | 2022 | 10 | |
| 17 | 2021 | 9 | |
| 18 | 2018 | 3 | |
| 19 | 2021 | 2 | |
| 20 | 2024 | 1 |
About Evan C. Lam
Evan C. Lam is a scholar working on Infectious Diseases, Immunology, Molecular Biology, Health and Cardiology and Cardiovascular Medicine, having authored 23 papers that have together received 2.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (17 papers), Viral gastroenteritis research and epidemiology (5 papers), HIV Research and Treatment (3 papers), Animal Virus Infections Studies (3 papers), Vaccine Coverage and Hesitancy (3 papers), COVID-19 Clinical Research Studies (3 papers), Viral Infections and Immunology Research (3 papers) and Infection Control and Ventilation (2 papers). The work is most often cited by research in Infectious Diseases (2.1k citations), Modeling and Simulation (219 citations), Health (235 citations), Animal Science and Zoology (277 citations) and Immunology (351 citations). Evan C. Lam has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Alejandro B. Balazs, Wilfredo F. García-Beltrán, A. John Iafrate, Aaron G. Schmidt, Blake M. Hauser, Jared Feldman, Adam D. Nitido, Kerri St. Denis, Vivek Naranbhai and David J. Gregory. Their work appears in journals such as Cell, Clinical Infectious Diseases, Science Translational Medicine, Nature Communications and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.